Replies to post #374792 on Elite Pharmaceuticals Inc (ELTP)

[imanjen13]

Lannett is not suffering from a shortage as stated on the FDA site. The shortage apparently is reflected by the TEVA short fall. Lannett is probably selling out their and Elite's DEA quota. Expect revenues to exceed $10 million for the quarter which ended in September.